Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ:ONVO). Though it will still be 3 – 5 years be…
Search Results For: organovo
3D bio-printing will access $3 billion market as Organovo CEO discusses latest results
Organovo CEO Keith Murphy came to the Q2 (FY 2017) analyst and investor call knowing that he would be on the receiving end of some potentially hostile questions. During October shares in the 3D bio-pr…
Organovo report increased sales, revenue passes $1m
3D bio-printing company, Organovo (NASDAQ:ONVO) have reported revenue for the quarter ended September 30, 2016. According to unaudited information filed with the Securities and Exchange Commission (SE…
3D bioprinting pioneer Organovo share price punished with 15% fall
Organovo (NASDAQ:ONVO) shares fell in response to a financing update yesterday: the company received a 15% hit to its stock price during NASDAQ trading. The California based 3D bioprinting company too…
Organovo
…
3D bioprinting Pioneer Organovo Announce 2016 financial results
For every star performing biotech, life sciences or innovative 3D printing company there are another 9 where investors would have been better off keeping their cash under a mattress. As Organovo repor…
Organovo's Samsara to Sell Liver Cells for Bioprinting
As with more traditional 3D printing technologies, an important part of bioprinting is the 3D printing material, meaning that there will be significant business opportunities for suppliers of biomatte…
Organovo Licenses Mini Kidneys for Bioprinting
Though Organovo produced 3D printed kidney cells earlier this year, last week, Professor Melissa Little‘s research team at the University of Queensland (UQ)’s Institute for Molecular Biosc…
Update: Organovo Justifies Secondary Stock Offering with Goals of $400M+ in Bioprinting Profits
3D bioprinting leader Organovo has been steadily growing this year, signing deals with pharmaceutical giant Merck and cosmetics company L’Oreal, as well as releasing news related to their first …
Organovo Signs Multi-Year 3D Bioprinting Deal with Pharma Giant Merck
After signing a groundbreaking deal with cosmetics company L’Oreal for the development of 3D printed skin for cosmetics testing, Organovo continues to make partners in powerful places. On April…